메뉴 건너뛰기




Volumn 134, Issue 3, 2014, Pages 565-571

Treatment of epistaxis in hereditary hemorrhagic telangiectasia with tranexamic acid - A double-blind placebo-controlled cross-over phase IIIB study

Author keywords

Antifibrinolytics; Epistaxis; Hereditary hemorrhagic telangiectasia; Osler Rendu Weber syndrome; Tranexamic acid

Indexed keywords

HEMOGLOBIN; PLACEBO; TRANEXAMIC ACID; ANTIFIBRINOLYTIC AGENT;

EID: 84923608476     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2014.06.012     Document Type: Article
Times cited : (76)

References (20)
  • 1
    • 79551624460 scopus 로고    scopus 로고
    • International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia
    • M.E. Faughnan, V.A. Palda, G. Garcia-Tsao, U.W. Geisthoff, J. McDonald, and D.D. Proctor et al. International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia J Med Genet 48 2011 73 87
    • (2011) J Med Genet , vol.48 , pp. 73-87
    • Faughnan, M.E.1    Palda, V.A.2    Garcia-Tsao, G.3    Geisthoff, U.W.4    McDonald, J.5    Proctor, D.D.6
  • 3
    • 0035922440 scopus 로고    scopus 로고
    • Efficacy of unusually high doses of tranexamic acid for the treatment of epistaxis in hereditary hemorrhagic telangiectasia
    • C. Sabba, M. Gallitelli, and G. Palasciano Efficacy of unusually high doses of tranexamic acid for the treatment of epistaxis in hereditary hemorrhagic telangiectasia N Engl J Med 345 2001 926
    • (2001) N Engl J Med , vol.345 , pp. 926
    • Sabba, C.1    Gallitelli, M.2    Palasciano, G.3
  • 4
    • 33947547747 scopus 로고    scopus 로고
    • Therapeutic action of tranexamic acid in hereditary haemorrhagic telangiectasia (HHT): Regulation of ALK-1/endoglin pathway in endothelial cells
    • L. Fernandez, E.M. Garrido-Martin, F. Sanz-Rodriguez, J.R. Ramirez, C. Morales-Angulo, and R. Zarrabeitia et al. Therapeutic action of tranexamic acid in hereditary haemorrhagic telangiectasia (HHT): regulation of ALK-1/endoglin pathway in endothelial cells Thromb Haemost 97 2007 254 262
    • (2007) Thromb Haemost , vol.97 , pp. 254-262
    • Fernandez, L.1    Garrido-Martin, E.M.2    Sanz-Rodriguez, F.3    Ramirez, J.R.4    Morales-Angulo, C.5    Zarrabeitia, R.6
  • 6
    • 0015610707 scopus 로고
    • Fibrinolytic activity in lesions of hereditary hemorrhagic telangiectasia
    • H.C. Kwaan, and S. Silverman Fibrinolytic activity in lesions of hereditary hemorrhagic telangiectasia Arch Dermatol 107 1973 571 573
    • (1973) Arch Dermatol , vol.107 , pp. 571-573
    • Kwaan, H.C.1    Silverman, S.2
  • 7
    • 0021980465 scopus 로고
    • Fibrinolytic activity in cutaneous lesions of hereditary hemorrhagic telangiectasia
    • M. Watanabe, S. Hanawa, and T. Morishima Fibrinolytic activity in cutaneous lesions of hereditary hemorrhagic telangiectasia Nihon Hifuka Gakkai Zasshi 95 1985 11 16
    • (1985) Nihon Hifuka Gakkai Zasshi , vol.95 , pp. 11-16
    • Watanabe, M.1    Hanawa, S.2    Morishima, T.3
  • 8
    • 0028027438 scopus 로고
    • Treatment of bleeding in hereditary hemorrhagic telangiectasia with aminocaproic acid
    • J.R. Korzenik, M.D. Topazian, and R. White Treatment of bleeding in hereditary hemorrhagic telangiectasia with aminocaproic acid N Engl J Med 331 1994 1236
    • (1994) N Engl J Med , vol.331 , pp. 1236
    • Korzenik, J.R.1    Topazian, M.D.2    White, R.3
  • 9
    • 84860005214 scopus 로고    scopus 로고
    • Intranasal tranexamic acid for the treatment of hereditary hemorrhagic telangiectasia: A case report and review of treatment options
    • B.A. Flanagan, C. Collins, and S. Parra Intranasal tranexamic acid for the treatment of hereditary hemorrhagic telangiectasia: a case report and review of treatment options Cutis 89 2012 69 72
    • (2012) Cutis , vol.89 , pp. 69-72
    • Flanagan, B.A.1    Collins, C.2    Parra, S.3
  • 11
    • 0019267976 scopus 로고
    • Clinical pharmacology of aminocaproic and tranexamic acids
    • I.M. Nilsson Clinical pharmacology of aminocaproic and tranexamic acids J Clin Pathol 33 Suppl. 14 1980 41 47
    • (1980) J Clin Pathol , vol.33 , Issue.SUPPL. 14 , pp. 41-47
    • Nilsson, I.M.1
  • 13
    • 0019485359 scopus 로고
    • Estrogen treatment of hereditary hemorrhagic telangiectasia. A double-blind controlled clinical trial
    • P. Vase Estrogen treatment of hereditary hemorrhagic telangiectasia. A double-blind controlled clinical trial Acta Med. Scand. 209 1981 393 396
    • (1981) Acta Med. Scand. , vol.209 , pp. 393-396
    • Vase, P.1
  • 14
    • 63249096929 scopus 로고    scopus 로고
    • Antiestrogen therapy for hereditary hemorrhagic telangiectasia: A double-blind placebo-controlled clinical trial
    • E. Yaniv, M. Preis, T. Hadar, J. Shvero, and M. Haddad Antiestrogen therapy for hereditary hemorrhagic telangiectasia: a double-blind placebo-controlled clinical trial Laryngoscope 119 2009 284 288
    • (2009) Laryngoscope , vol.119 , pp. 284-288
    • Yaniv, E.1    Preis, M.2    Hadar, T.3    Shvero, J.4    Haddad, M.5
  • 15
    • 84929931605 scopus 로고    scopus 로고
    • Intranasal submucosal bevacizumab for epistaxis in hereditary hemorrhagic telangiectasia, a double blind, randomized, placebo controlled trial
    • 10.1002/hed.23655 (Mar 4.)
    • D. Riss, M. Burian, A. Wolf, V. Kranebitter, A. Kaider, and C. Arnoldner Intranasal submucosal bevacizumab for epistaxis in hereditary hemorrhagic telangiectasia, a double blind, randomized, placebo controlled trial Head Neck 2014 10.1002/hed.23655 (Mar 4.)
    • (2014) Head Neck
    • Riss, D.1    Burian, M.2    Wolf, A.3    Kranebitter, V.4    Kaider, A.5    Arnoldner, C.6
  • 16
    • 0032560732 scopus 로고    scopus 로고
    • Hemostatic drugs
    • P.M. Mannucci Hemostatic drugs N Engl J Med 339 1998 245 253
    • (1998) N Engl J Med , vol.339 , pp. 245-253
    • Mannucci, P.M.1
  • 17
    • 79951619464 scopus 로고    scopus 로고
    • Antifibrinolytic therapy with tranexamic acid in pregnancy and postpartum
    • P. Peitsidis, and R.A. Kadir Antifibrinolytic therapy with tranexamic acid in pregnancy and postpartum Expert Opin Pharmacother 12 2011 503 516
    • (2011) Expert Opin Pharmacother , vol.12 , pp. 503-516
    • Peitsidis, P.1    Kadir, R.A.2
  • 19
    • 36049038657 scopus 로고    scopus 로고
    • Elevated factor VIII in hereditary haemorrhagic telangiectasia (HHT): Association with venous thromboembolism
    • C.L. Shovlin, N.L. Sulaiman, F.S. Govani, J.E. Jackson, and M.E. Begbie Elevated factor VIII in hereditary haemorrhagic telangiectasia (HHT): association with venous thromboembolism Thromb Haemost 98 2007 1031 1039
    • (2007) Thromb Haemost , vol.98 , pp. 1031-1039
    • Shovlin, C.L.1    Sulaiman, N.L.2    Govani, F.S.3    Jackson, J.E.4    Begbie, M.E.5
  • 20
    • 0033005358 scopus 로고    scopus 로고
    • Tranexamic acid: A review of its use in surgery and other indications
    • C.J. Dunn, and K.L. Goa Tranexamic acid: a review of its use in surgery and other indications Drugs 57 1999 1005 1032
    • (1999) Drugs , vol.57 , pp. 1005-1032
    • Dunn, C.J.1    Goa, K.L.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.